Chemoinformaics analysis of (1-Hydroxy-2,4,4-trimethylpentan-3-yl) 2-methylpropanoate
Molecular Weight | 216.321 | nRot | 4 |
Heavy Atom Molecular Weight | 192.129 | nRig | 21 |
Exact Molecular Weight | 216.173 | nRing | 0 |
Solubility: LogS | -4.385 | nHRing | 0 |
Solubility: LogP | 2.384 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 38.449 |
nHD | 1 | BPOL | 26.681 |
QED | 0.867 |
Synth | 3.578 |
Natural Product Likeliness | 0.936 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.822 |
Pgp-sub | 0.032 |
HIA | 0.005 |
CACO-2 | -4.854 |
MDCK | 0.0000637 |
BBB | 0.125 |
PPB | 0.926605 |
VDSS | 1.139 |
FU | 0.0574745 |
CYP1A2-inh | 0.032 |
CYP1A2-sub | 0.941 |
CYP2c19-inh | 0.225 |
CYP2c19-sub | 0.899 |
CYP2c9-inh | 0.296 |
CYP2c9-sub | 0.801 |
CYP2d6-inh | 0.242 |
CYP2d6-sub | 0.916 |
CYP3a4-inh | 0.602 |
CYP3a4-sub | 0.709 |
CL | 6.164 |
T12 | 0.293 |
hERG | 0.218 |
Ames | 0.274 |
ROA | 0.202 |
SkinSen | 0.602 |
Carcinogencity | 0.25 |
EI | 0.146 |
Respiratory | 0.335 |
NR-Aromatase | 0.791 |
Antiviral | Yes |
Prediction | 0.725776 |